XML 74 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2014
Earnings Per Share [Abstract]  
Schedule Of Earnings Per Share

 

For the three months ended

 

For the nine months ended

 

September 30,

 

September 30,

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

 

Net income (in millions)

$

211 

 

$

186 

 

$

612 

 

$

559 

 

 

 

 

 

 

 

 

 

 

 

 

Number of common shares:

 

 

 

 

 

 

 

 

 

 

 

Weighted average outstanding

 

351,457,043 

 

 

350,517,337 

 

 

351,357,913 

 

 

350,334,634 

Issued upon assumed exercise of outstanding stock options

 

235,944 

 

 

373,152 

 

 

354,940 

 

 

442,678 

Effect of issuance of nonvested restricted common stock

 

514,668 

 

 

332,341 

 

 

484,786 

 

 

237,662 

Effect of issuance of nonvested performance units

 

119,595 

 

 

–  

 

 

136,907 

 

 

–  

Weighted average and potential dilutive outstanding (1)(2)

 

352,327,250 

 

 

351,222,830 

 

 

352,334,546 

 

 

351,014,974 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.60 

 

$

0.53 

 

$

1.74 

 

$

1.60 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

$

0.60 

 

$

0.53 

 

$

1.74 

 

$

1.59 

 

(1)

Options for 1,254,842 shares and 27,916 shares of restricted stock were excluded from the calculation for the three months ended September 30, 2014 because they would have had an antidilutive effect.  Options for 1,550,838 shares and 15,703 shares of restricted stock were excluded from the calculation for the three months ended September 30, 2013 because they would have had an antidilutive effect.

(2)

Options for 1,111,128 shares and 24,215 shares of restricted stock were excluded from the calculation for the nine months ended September 30, 2014 because they would have had an antidilutive effect.  Options for 1,848,566 shares and 169,261 shares of restricted stock were excluded from the calculation for the nine months ended September 30, 2013 because they would have had an antidilutive effect.